Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subanesthetic esketamine for postoperative recovery in frail hip arthroplasty patients
ChiCTR2600126626Phase 4Completed
- Sponsor
- Huaihe Hospital of Henan University
- Start
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine in Neck Of Femur Fracture, postoperative pain, anxiety disorder and 2 more (2 arms), sponsored by Huaihe Hospital of Henan University. Primary endpoint: 24-hour Quality of Recovery. Started Jun 2026; status: completed.
02
Drugs
esketamine
03
Conditions
Neck Of Femur Fracturepostoperative painanxiety disorderpostoperative depressionpostoperative delirium (POD)
Beyond the preview
Go deeper on ChiCTR2600126626.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600126626.